Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF): An 8-year Observational Study at a Single Center

Por Izzedine, Hassan, Escudier, Bernard, Lhomme, Catherine, Pautier, Patricia, Rouvier, Philippe, Gueutin, Victor, Baumelou, Alain, Derosa, Lisa, Bahleda, Rastilav, Hollebecque, Antoine, Sahali, Djillali, Soria, Jean Charles
Publicado no Medicine (Baltimore) (2014)

Renal Cell Carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumors

Por Karlo, Christoph A., Kou, Lei, Paolo, Pier Luigi Di, Kattan, Michael W., Motzer, Robert J., Russo, Paul, Tickoo, Satish K., Akin, Oguz, Hricak, Hedvig
Publicado no Eur J Cancer (2016)

Renal Cell Cancer Treated with a Single-Edged Sword

Por Emerson Lim, Edward P. Gelmann
Publicado em 2013-02-01

The clinical significance of lymphangiogenesis in renal cell carcinoma

Por Dębiński, Paweł, Dembowski, Janusz, Kowal, Paweł, Szydełko, Tomasz, Kołodziej, Anna, Małkiewicz, Bartosz, Tupikowski, Krzysztof, Zdrojowy, Romuald
Publicado em 2013

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma

Por Yoshimura, K, Minami, T, Nozawa, M, Uemura, H
Publicado em 2013

RESULTS OF CLINICAL TRIALS OF MEDICAL TREA TMENT OF RENAL CELL CARCINOMA IN 2014–2015

Por A. M. Popov, O. B. Karyakin, A. D. Kaprin
Publicado em 2016-01-01

Radical retropubic and perineal prostatectomy for clinically localised prostate cancer in renal transplant recipients

Por Heidenreich, Axel, Pfister, David, Thissen, Andrea, Piper, Charlotte, Porres, Daniel
Publicado no Arab J Urol (2014)

MicroRNA-23b* targets proline oxidase, a mitochondrial tumor suppressor protein in renal cancer

Por Liu, W, Zabirnyk, O, Wang, H, Shiao, Y-H, Nickerson, M L, Khalil, S, Anderson, L M, Perantoni, A O, Phang, J M
Publicado no Oncogene (2010)

Expression of PDL-1 Receptors in Prostate Cancer Patients and its Association with Tumour Aggressiveness: A Cross-sectional Study

Por Gaurav Gupta, Sumit Gahlawat, HEMANT GOEL, Ravi Kant Singh, Karandeep Guleria, RAJEEV SOOD
Publicado em 2022-02-01

Urological cancers

Por Waxman, Jonathan.
Publicado em 2005

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal...

Por Dong Fang, Shiming He, Gengyan Xiong, Nirmish Singla, Zhenpeng Cao, Lei Zhang, Xuesong Li, Liqun Zhou
Publicado em 2018-03-01

Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma

Por Nagaraja, H., Srivatsa, N., Hemalatha, S., Shweta, S., Raghunath, S. K.
Publicado no Indian J Surg Oncol (2018)

Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis

Por Wang, Jian, Zhao, Jiqing, Shi, Mengjing, Ding, Yu, Sun, Huiqin, Yuan, Fahuan, Zou, Zhongmin
Publicado em 2014

Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

Por Huang, Dan, Ding, Yan, Zhou, Ming, Rini, Brian I., Petillo, David, Qian, Chao-Nan, Kahnoski, Richard, Futreal, P. Andrew, Furge, Kyle A., Teh, Bin Tean
Publicado em 2010

EVALUATION OF PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM

Por Thompson, R. Houston, Siddiqui, Sameer, Lohse, Christine M., Leibovich, Bradley C., Russo, Paul, Blute, Michael L.
Publicado em 2009

Secondary tumours of the ampulla of Vater: Case report and review of the literature

Por Sarocchi, Francesca, Gilg, Magdalena M., Schreiber, Florian, Langner, Cord
Publicado no Mol Clin Oncol (2018)

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

Por Hanavan, Paul D., Borges, Chad R., Katchman, Benjamin A., Faigel, Douglas O., Ho, Thai H., Ma, Chen-Ting, Sergienko, Eduard A., Meurice, Nathalie, Petit, Joachim L., Lake, Douglas F.
Publicado no Oncotarget (2015)

Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

Por Tsao, Che-Kai, Liaw, Bobby, He, Catherine, Galsky, Matthew D., Sfakianos, John, Oh, William K.
Publicado no Ther Adv Med Oncol (2017)

Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study

Por Guo Q, Zhang C, Guo X, Tao F, Xu Y, Feng G, Han X, Ren Z, Zhang H, Zhang P, Wang X, Wang G
Publicado em 2018-08-01

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression

Por Lipkin, Jacob S, Rizvi, Syed M, Gatalica, Zoran, Sarwani, Nabeel E, Holder, Sheldon L, Kaag, Mathew, Drabick, Joseph J, Joshi, Monika
Publicado no Cancer Biol Ther (2015)